| ID Source | ID |
|---|---|
| PubMed CID | 9811445 |
| CHEMBL ID | 420873 |
| CHEMBL ID | 185463 |
| CHEMBL ID | 1185552 |
| MeSH ID | M0587002 |
| Synonym |
|---|
| 1$l^{5},7$l^{5},15,21-tetraazapentacyclo[20.6.2.2^{7,14}.0^{8,13}.0^{23,28}]dotriaconta-1(28),7,9,11,13,22,24,26,29,31-decaene-1,7-bis(ylium) |
| gtpl2321 |
| ucl1848 |
| 1,7-diazonia-15,21-diazapentacyclo[20.6.2.27,14.08,13.023,28]dotriaconta-1(28),7(32),8,10,12,14(31),22,24,26,29-decaene |
| bdbm50092131 |
| CHEMBL420873 , |
| ucl-1848 |
| CHEMBL185463 |
| CHEMBL1185552 |
| Q27089054 |
| PD119485 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1346463 | Rat KCa2.3 (Calcium- and sodium-activated potassium channels) | 2001 | The Journal of physiology, Sep-01, Volume: 535, Issue:Pt 2 | SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neurones. |
| AID1346442 | Human KCa2.2 (Calcium- and sodium-activated potassium channels) | 2001 | The Journal of biological chemistry, Apr-13, Volume: 276, Issue:15 | Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. |
| AID1346449 | Human KCa2.1 (Calcium- and sodium-activated potassium channels) | 2000 | British journal of pharmacology, Feb, Volume: 129, Issue:4 | The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines. |
| AID1346438 | Rat KCa2.2 (Calcium- and sodium-activated potassium channels) | 2004 | The Journal of biological chemistry, Jan-09, Volume: 279, Issue:2 | The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system. |
| AID754048 | Inhibition of KCa2.3 in Sprague-Dawley rat superior cervical ganglion neurons assessed as inhibition of afterhyperpolarization by electrophysiological assay | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Further studies on bis-charged tetraazacyclophanes as potent inhibitors of small conductance Ca(2+)-activated K+ channels. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||